Skip to main content
Clinical Trials/NCT03044951
NCT03044951
Unknown
Not Applicable

Cryoballoon Versus Irrigated Radiofrequency Ablation in Patients With Paroxysmal Atrial Fibrillation: A Multi-center, Prospective, Randomized, Controlled Study

Ruijin Hospital1 site in 1 country600 target enrollmentNovember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Ruijin Hospital
Enrollment
600
Locations
1
Primary Endpoint
Efficacy endpoint (time to first documented clinical recurrence after blanking period)
Last Updated
9 years ago

Overview

Brief Summary

It's a multi-center, prospective, randomized, controlled clinical trial of cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation.

Detailed Description

The hypothesis of this study is that pulmonary vein isolation with cryoballoon ablation is not inferior to radiofrequency ablation with 3D mapping with respect to clinical safety and efficacy.

Registry
clinicaltrials.gov
Start Date
November 2016
End Date
December 2020
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Qi Jin

Clinical Professor

Ruijin Hospital

Eligibility Criteria

Inclusion Criteria

  • ECG recording of atrial fibrillation
  • first time of ablation
  • refractory to at least one anti-arrhythmia drug
  • sign informed consent for participation in the study

Exclusion Criteria

  • had ablation before
  • serious heart failure
  • left atrial diameter\>55mm
  • Myocardial infarction, heart surgery or coronary intervention in 3 months before the ablation
  • Stroke in 6 months before the ablation
  • Endocardial thrombosis

Outcomes

Primary Outcomes

Efficacy endpoint (time to first documented clinical recurrence after blanking period)

Time Frame: one year

the time to first documented clinical recurrence after blanking period (month)

Safety endpoint (Any procedure-related complications)

Time Frame: one year

Any procedure-related complications

Secondary Outcomes

  • QoL changes at 12 months (Units on a Scale)(one year)
  • X-ray time (min)(one year)
  • Procedure time (min)(one year)
  • Left atrial time (min)(one year)
  • time to first time cardiovascular hospitalization (month)(one year)

Study Sites (1)

Loading locations...

Similar Trials